GleamWall
中文EN

IBAC IB Acquisition Corp.

Services-Commercial Physical & Biological Research · Nasdaq · SEC CIK 1998781 · Fiscal year ends 09/30

Financial factors as of 2026-03-31 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-74.6%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA1.5%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets21.7%
Debt / equity—
Current ratio0.16x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-1.54x
Accruals ratio3.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-06-302026Q22026-03-312026Q12025-12-312025Q4*2025-09-302025Q32025-06-302025Q22025-03-312025Q12024-12-312024Q4*2024-09-30
Income statement
Revenue————————
SG&A expense$624,429$748,177$180,000$236,772$172,210$163,485$176,441$165,458
Operating income-$624,429-$748,177-$180,000-$236,772-$172,210-$163,485-$176,441-$165,458
Interest expense———————-$1.52M
Pretax income-$551,944-$611,075-$26,711$1.02M$1.08M$1.09M$1.20M$1.36M
Income tax$15,222$28,791$32,191$151,702$263,382$262,530$288,021$320,658
Net income-$567,166-$639,866-$58,902$866,365$818,610$824,126$907,068$1.04M
EPS (diluted)————————
Balance sheet
Cash & equivalents$30,161$4,634$165,484$428,700$486,018$627,375$910,193$822,799
Current assets$256,535$288,431$361,778$1.24M$623,225$864,955$1.17M$1.20M
Total assets$8.52M$8.48M$16.41M$17.13M$122.18M$121.16M$120.83M$119.80M
Current liabilities—$1.84M$1.16M$1.83M$549,009$355,147$846,324$722,230
Total liabilities$2.45M$1.84M$1.16M$1.83M$549,009$355,147$846,324$722,230
Shareholders' equity-$2.31M-$1.69M-$861,323-$681,323$599,661$771,871$935,356$1.11M
Shares outstanding4.25M4.25M4.25M4.25M4.25M4.25M4.25M4.25M
Cash flow statement
Operating cash flow-$474,473-$265,850-$1.05M-$57,319-$141,357-$744,189-$375,235-$53,850
Investing cash flow$0——$106.92M$0$609,000$315,000$0
Financing cash flow$500,000—————$147,629$0
Share buybacks$0———————

Free plan shows the latest 8 periods; Pro shows all 15 🔒

· This company does not report gross profit in XBRL.

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.